Rare bee 'beach' habitat backed by sand donation
The conservation effort is being carried out at Pelsall North Common in Walsall, with the sand being used to create a further two beaches in the reserve.
It is part of the Purple Horizons Nature Recovery Project, led by Natural England. The work involves using diggers to remove vegetation and create bare ground areas - known as 'bee beaches' - which are crucial habitats for many threatened pollinators.
The project, now in its second year, has created bee-friendly habitats across seven sites in the region.
These are Shire Oak Park, Barr Beacon, Pelsall North Common, Chasewater Country Park, Brownhills Common, Wharf Lane and Muckley Corner.
The sand used to create the newest two bee beaches was collected as part of ongoing work at Tamworth Road Narrows carried out by the Lichfield & Hatherton Canals Restoration Trust.
Derek Lord from the trust said they were proud to support "such an important conservation initiative" by repurposing excess sand excavated from the Lichfield Canal channel.
"Creating sustainable habitats and enhancing biodiversity is one of our core aims," he said.
"While our focus is obviously along the blue-green corridor of the Lichfield Canal it's a real bonus to be able to extend that impact to another location."
Walsall councillor Gary Fling said: "This project continues to go from strength to strength and Walsall is proud to be playing its part in preserving and restoring these habitats."
Bees spotted
Purple Horizons is being delivered by a partnership between Walsall Council, Staffordshire County Council, Lichfield District Council, Natural England, University of Birmingham researchers, and the Birmingham and Black Country Wildlife Trust.
Nationally, around 80% of heathlands have been lost since 1800 and globally the habitat is rarer than a tropical rainforest.
Last year, two "near-threatened" species of bees were spotted thriving at Barr Beacon local nature reserve in Walsall thanks to the project.
The discovery of the Cats Ear Mining Bee (Andrena humilis) and the Cats Ear Nomad Bee (Nomada integra) was made by Aaron Bhambra, a researcher at the University of Birmingham.
Follow BBC Birmingham on BBC Sounds, Facebook, X and Instagram.
Rare bee species found thriving in Walsall
Birmingham named UK's first Nature City
Warwickshire is the place to bee
Wild flowers attract rare bees to urban common
Something has gone wrong for insects, says charity
Related internet links
Natural England
Walsall Council
Purple Horizons
University of Birmingham
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
How to Maximize the Health Benefits of Walking
Credit - Ruslan Dashinsky—Getty Images Walking has many demonstrated health benefits: improving heart health, lowering blood sugar, burning calories for weight loss, and improving muscle tone. But most of the research on walking has focused on how long people walk, not how quickly. Recent studies have hinted that altering your walking pace—which has become popular as Japanese walking (also known as interval walking)—might have additional benefits. In a study published in the American Journal of Preventive Medicine, researchers led by Dr. Wei Zheng, professor and director of the Vanderbilt University Epidemiology Center, studied whether walking pace made a difference in people's health. They studied 86,000 people who reported how much they walked each day, as well as other health-related activities such as their diet and whether they smoked or drank alcohol. Over 17 years, the researchers tracked their death rates and correlated mortality to their walking pattern. They found that people who walked at a faster pace for at least 15 minutes a day had a lower risk of dying during the study period than those who walked more slowly. Both groups lowered their risk of death during that time, but the reduction was more impressive among those who regularly walked at a brisker pace. Read More: Why Walking Isn't Enough When It Comes to Exercise While those findings may not be entirely surprising, Zheng says the trial focused on a group of people who aren't typically part of exercise studies. About half of the people in the trial made less than $15,000 a year, and two-thirds of the participants were Black. Studies have documented that these groups 'are at high risk of many diseases including diabetes and hypertension,' says Zheng—so the lower mortality rate is especially reassuring, since it represents a relatively low impact and low cost way to improve health. Current government health recommendations advise moderate exercise for at least 30 minutes most days of the week, and Zheng says that his study shows that even 15 minutes a day can provide benefits. That's good news for people who may currently be sedentary and for whom starting an exercise program can be challenging. 'If you walk just 15 minutes a day, which is below the recommended level [of exercise], you still benefit,' he says. And while the results showed that people who walked the fastest had the greatest reduction in mortality, Zheng says it's important to remember that even people walking at a slower pace showed some benefit. That suggests that if people continue walking, even at a slower pace, and add a few minutes of faster paced walking into their regimen, they could increase their health benefits. Such interval training has long been popular in exercise regimens, but the latest data suggest it applies to walking as well. Contact us at letters@ Solve the daily Crossword
Yahoo
7 hours ago
- Yahoo
Centauri Therapeutics Receives an Additional $5.1M from CARB-X to Progress ABX-01 Lead Compound to First in Human Clinical Trials
CARB-X provides an additional $5.1M to complete the non-clinical safety and efficacy studies with ABX-01 lead candidate Centauri plans the progression of lead candidate, an immunotherapy based broad-spectrum antimicrobial, to a first in human clinical study in early 2026 CARB-X's additional funding brings their financial support to date for the Alphamer platform and lead compound non-clinical development to $12.3M ALDERLEY PARK, England, July 29, 2025--(BUSINESS WIRE)--Centauri Therapeutics Limited ('Centauri' or 'the Company'), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, announced today that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has provided an additional $5.1M in funding for the development of their lead compound. The funds will contribute to the advancement of the lead candidate in Centauri's ABX-01 programme into first in human clinical studies, and this latest funding brings CARB-X's total support from 2019 to date to $12.3M. Centauri announced the selection of its first clinical candidate in the ABX-01 programme in March 20251. The candidate is a broad-spectrum antimicrobial specifically selected to combat clinically prevalent and multidrug-resistant bacterial strains. Based on the Company's proprietary Alphamer® platform, it is designed to target serious Gram-negative bacterial infections in the lung, expanding therapeutic options for the most vulnerable patients. It employs a dual mechanism of action, combining immunotherapeutic effects through complement fixation and phagocytosis with intrinsic antibacterial properties, within a single molecule. Early efficacy studies have demonstrated the compound's activity against Gram-negative bacteria. "The unwavering scientific and financial support from CARB-X has provided stability to Centauri as a company, expanded understanding of our Alphamer platform, and enabled us to progress the ABX-01 programme from discovery, through early development, and is now providing a smooth and continuous path towards First in Human clinical studies," said Dr. Jennifer Schneider, Chief Executive Officer, Centauri Therapeutics. "We are thankful for CARB-X and their continued engagement and confidence, which has allowed us to move a step closer to delivering a much needed therapeutic for serious, drug-resistant Gram-negative infections, even in the most clinically vulnerable patients." Dr. Erin Duffy, Chief of Research and Development, CARB-X, commented: "We have been proud to support Centauri, beginning with answering key questions on the approach and continuing with the drug discovery that has led to the lead asset of ABX-01 and its progression towards building a dossier to support its advancement into first in human clinical trials." CARB-X's funding for this project is provided in part with federal funds from the U.S. Department of Health and Human Services (HHS); Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; under agreement number: 75A50122C00028, and by awards from Wellcome (WT224842), and Germany's Federal Ministry of Research, Technology and Space (BMFTR). The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of CARB-X or any of its funders. Press Release (4th March, 2025): Centauri Therapeutics selects first clinical candidate, for immunotherapeutic treatment of Gram-negative bacterial infections View source version on Contacts Media contact Katie OdgaardEmail: Tel: +44 (0) 7787 502 947 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Time Magazine
12 hours ago
- Time Magazine
How to Maximize the Health Benefits of Walking
Walking has many demonstrated health benefits: improving heart health, lowering blood sugar, burning calories for weight loss, and improving muscle tone. But most of the research on walking has focused on how long people walk, not how quickly. Recent studies have hinted that altering your walking pace—which has become popular as Japanese walking (also known as interval walking)—might have additional benefits. In a study published in the American Journal of Preventive Medicine, researchers led by Dr. Wei Zheng, professor and director of the Vanderbilt University Epidemiology Center, studied whether walking pace made a difference in people's health. They studied 86,000 people who reported how much they walked each day, as well as other health-related activities such as their diet and whether they smoked or drank alcohol. Over 17 years, the researchers tracked their death rates and correlated mortality to their walking pattern. They found that people who walked at a faster pace for at least 15 minutes a day had a lower risk of dying during the study period than those who walked more slowly. Both groups lowered their risk of death during that time, but the reduction was more impressive among those who regularly walked at a brisker pace. Read More: Why Walking Isn't Enough When It Comes to Exercise While those findings may not be entirely surprising, Zheng says the trial focused on a group of people who aren't typically part of exercise studies. About half of the people in the trial made less than $15,000 a year, and two-thirds of the participants were Black. Studies have documented that these groups 'are at high risk of many diseases including diabetes and hypertension,' says Zheng—so the lower mortality rate is especially reassuring, since it represents a relatively low impact and low cost way to improve health. Current government health recommendations advise moderate exercise for at least 30 minutes most days of the week, and Zheng says that his study shows that even 15 minutes a day can provide benefits. That's good news for people who may currently be sedentary and for whom starting an exercise program can be challenging. 'If you walk just 15 minutes a day, which is below the recommended level [of exercise], you still benefit,' he says. And while the results showed that people who walked the fastest had the greatest reduction in mortality, Zheng says it's important to remember that even people walking at a slower pace showed some benefit. That suggests that if people continue walking, even at a slower pace, and add a few minutes of faster paced walking into their regimen, they could increase their health benefits. Such interval training has long been popular in exercise regimens, but the latest data suggest it applies to walking as well.
